MedTrace Logo

Renal Safety of Bowel Preparation With Polyethylene Glycol

NCT02657564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1237

Last updated 2019-02-05

Study results available
· View outcomes & findings →

Summary

This study evaluates the changes of renal function after taking bowel cleansing agent polyethylene glycol for elective colonoscopy.

Conditions

Interventions

DRUG

Polyethylene glycol (PEG)

Participants receive blood tests for serum creatinine and electrolytes (Ca, P, Cl, Mg, Na, K) before and after taking polythylene glycol.

Sponsors & Collaborators

  • Evergreen General Hospital, Taiwan

    lead OTHER

Principal Investigators

  • Chiliang Cheng, MD · Zhongli Evergreen General Hospital, Taiwan

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657564 on ClinicalTrials.gov